The Merril Lynch and Co., Biotech HOLDRs ETF opens the week at $99.14 a share. The biotechnology exchanged traded fund is heavily weighted toward three stocks within the sector, Amgen, Gilead and Biogen.
The Biotech HOLDRs Fund Inception Date: November 22, 1999
Biotech HOLDRs ETF price chart BBH
The Biotech HOLDRs ETF (stock symbol BBH) provides exposure to stocks across the biotechnology sector.
The top components for the Biotech HOLDRs ETF:
Amgen Inc. AMGN 36.89%
Gilead Sciences, Inc. GILD 22.66%
Biogen Idec Inc BIIB 16.16%
Genzyme Corporation GENZ 10.64%
SHIRE SHP.L 5.01%
Life Technologies Corporation LIFE 4.29%
Human Genome Sciences, Inc. HGSI 2.61%
Alkermes, Inc. ALKS 0.59%
Enzon Pharmaceuticals, Inc. ENZN 0.35
Biotech HOLDRs ETF
